Evidence map›Paper›PMID 19098427›Full record

ArticleCell cycle (Georgetown, Tex.)2008

T cell survival and function requires the c-Abl tyrosine kinase.

Isabelle Silberman, Ronit Vogt Sionov, Valentina Zuckerman, Sue Haupt, Zehavit Goldberg, Andreas Strasser, Zami S Ben-Sasson, Michal Baniyash, Anthony J Koleske, Ygal Haupt

Abstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Cancers · 2020
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Abl family kinases regulate FcγR-mediated phagocytosis in murine macrophages.Journal of immunology (Baltimore, Md. : 1950) · 2012
    Article
  11. Article
  12. Article
  13. Article
  14. c-Abl in neurodegenerative disease.Journal of molecular neuroscience : MN · 2011
    Review
  15. Review
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Isabelle SilbermanLautenberg Center for General and Tumor Immunology, Hadassah Medical School, The Hebrew University, Jerusalem, Israel.
Ronit Vogt Sionov
Valentina Zuckerman
Sue Haupt
Zehavit Goldberg
Andreas Strasser
Zami S Ben-Sasson
Michal Baniyash
Anthony J Koleske
Ygal Haupt

Funding

Roles of Abl and Arg Neuronal DevelopmentR01NS039475 · NINDS · YALE UNIVERSITY · PI KOLESKE, ANTHONY J · 2000 to 2012
$4.3M
Biochemical screen--regulators of neuronal morphogenesisR21MH077306 · NIMH · YALE UNIVERSITY · PI KOLESKE, ANTHONY J · 2006 to 2007
$398k
NIMH NIH HHS R21 MH077306NINDS NIH HHS R01 NS039475
6 · The paper itself

Abstract

C-Abl (Abl) regulates multiple cellular processes, including proliferation, survival, shape determination and motility, and participates in cellular responses to genotoxic and oxidative stress stimuli. Mice lacking Abl exhibit retarded growth, osteoporosis and defects in the immune system resulting in lymphopoenia and susceptibility to infections, leading to early death. To define the role of Abl in the regulation of adult T cells we ablated Abl exclusively in T cells by generating mice with floxed abl alleles and expressing an Lck-Cre transgene (Abl-T(-/-)). These mice exhibited thymic atrophy and abnormally reduced T cell numbers in the periphery. The thymic atrophy was caused by increased susceptibility of thymocytes to cell death. Importantly, Abl deficient T cells displayed abnormally reduced response to mitogenic stimulation in vitro. Consequently, Abl-T(-/-) mice exhibited impaired ability to reject syngeneic tumor, to induce T-mediated tumor cell killing, and to generate anti-tumor antibodies. These results demonstrate a cell-autonomous role for Abl in T cell function and survival.

Indexed as

AnimalsAtrophyCell DeathDisease SusceptibilityInterleukin-2LymphopeniaMiceMice, KnockoutMitogensNeoplasm TransplantationProto-Oncogene Proteins c-ablT-LymphocytesInterleukin-2MitogensProto-Oncogene Proteins c-abl

Identifiers

PMID19098427
PMCPMC3407662
OpenAlexW1987056320

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.